These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36935853)

  • 21. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
    Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Online adaptive radiotherapy: Assessment of planning technique and its impact on longitudinal plan quality robustness in pancreatic cancer.
    Mittauer KE; Yarlagadda S; Bryant JM; Bassiri N; Romaguera T; Gomez AG; Herrera R; Kotecha R; Mehta MP; Gutierrez AN; Chuong MD
    Radiother Oncol; 2023 Nov; 188():109869. PubMed ID: 37657726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.
    Fink CA; Buchele C; Baumann L; Liermann J; Hoegen P; Ristau J; Regnery S; Sandrini E; König L; Rippke C; Bonekamp D; Schlemmer HP; Debus J; Koerber SA; Klüter S; Hörner-Rieber J
    Front Oncol; 2024; 14():1308406. PubMed ID: 38425342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results.
    Michalet M; Bettaïeb O; Khalfi S; Ghorbel A; Valdenaire S; Debuire P; Aillères N; Draghici R; De Méric De Bellefon M; Charissoux M; Boisselier P; Demontoy S; Marguerit A; Cabaillé M; Cantaloube M; Keskes A; Bouhafa T; Farcy-Jacquet MP; Fenoglietto P; Azria D; Riou O
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System.
    Chow PE; Chu FI; Agazaryan N; Cao M; Tyran M; Yang Y; Low D; Raldow A; Lee P; Steinberg M; Lamb JM
    Adv Radiat Oncol; 2021; 6(3):100682. PubMed ID: 33898868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiation Therapy (CT-STAR) for the Treatment of Abdominal Oligometastases.
    Schiff JP; Stowe HB; Price A; Laugeman E; Hatscher C; Hugo GD; Badiyan SN; Kim H; Robinson CG; Henke LE
    Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):1022-1031. PubMed ID: 35768023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Outcomes of Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Adrenal Metastases from a Single Institution.
    Hoegen-Saßmannshausen P; Jessen I; Buchele C; Schlüter F; Rippke C; Renkamp CK; Weykamp F; Regnery S; Liermann J; Meixner E; Hoeltgen L; Eichkorn T; König L; Debus J; Klüter S; Hörner-Rieber J
    Cancers (Basel); 2024 Jun; 16(12):. PubMed ID: 38927978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer.
    Waters M; Price A; Laugeman E; Henke L; Hugo G; Stowe H; Andruska N; Brenneman R; Hao Y; Green O; Robinson C; Gay H; Michalski J; Baumann BC
    Clin Transl Radiat Oncol; 2024 Jan; 44():100693. PubMed ID: 38021093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-shaping using targeted sparse optimization.
    Sayre GA; Ruan D
    Med Phys; 2013 Jul; 40(7):071711. PubMed ID: 23822415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
    Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
    Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Silico Single-Fraction Stereotactic Ablative Radiation Therapy for the Treatment of Thoracic and Abdominal Oligometastatic Disease With Online Adaptive Magnetic Resonance Guidance.
    Lee S; Yadav P; van der Kogel AJ; Bayouth J; Bassetti MF
    Adv Radiat Oncol; 2021; 6(3):100652. PubMed ID: 34195490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomes.
    Regnery S; Buchele C; Piskorski L; Weykamp F; Held T; Eichkorn T; Rippke C; Katharina Renkamp C; Klüter S; Ristau J; König L; Koerber SA; Adeberg S; Debus J; Hörner-Rieber J
    Radiother Oncol; 2022 Mar; 168():106-112. PubMed ID: 35121031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of patients with locally advanced pancreatic cancer benefitting from plan adaptation in MR-guided radiation therapy.
    Bohoudi O; Bruynzeel AME; Meijerink MR; Senan S; Slotman BJ; Palacios MA; Lagerwaard FJ
    Radiother Oncol; 2019 Mar; 132():16-22. PubMed ID: 30825964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study.
    Michalet M; Bordeau K; Cantaloube M; Valdenaire S; Debuire P; Simeon S; Portales F; Draghici R; Ychou M; Assenat E; Dupuy M; Gourgou S; Colombo PE; Carrere S; Souche FR; Aillères N; Fenoglietto P; Azria D; Riou O
    Front Oncol; 2022; 12():842402. PubMed ID: 35356227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer.
    Bohoudi O; Bruynzeel AME; Senan S; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Palacios MA
    Radiother Oncol; 2017 Dec; 125(3):439-444. PubMed ID: 28811038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of online MR-guided multi-fraction stereotactic ablative radiotherapy in lung tumours.
    Hering S; Nieto A; Marschner S; Hofmaier J; Schmidt-Hegemann NS; da Silva Mendes V; Landry G; Niyazi M; Manapov F; Belka C; Corradini S; Eze C
    Clin Transl Radiat Oncol; 2024 Mar; 45():100736. PubMed ID: 38433949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating the impact of patient arm position in an MR-linac on liver SBRT treatment plans.
    van den Wollenberg W; de Ruiter P; Nowee ME; Jansen EPM; Sonke JJ; Fast MF
    Med Phys; 2019 Nov; 46(11):5144-5151. PubMed ID: 31529694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose Escalation for Pancreas SBRT: Potential and Limitations of using Daily Online Adaptive Radiation Therapy and an Iterative Isotoxicity Automated Planning Approach.
    Rhee DJ; Beddar S; Jaoude JA; Sawakuchi G; Martin R; Perles L; Yu C; He Y; Court LE; Ludmir EB; Koong AC; Das P; Koay EJ; Taniguichi C; Niedzielski JS
    Adv Radiat Oncol; 2023; 8(4):101164. PubMed ID: 36798731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate.
    Nierer L; Eze C; da Silva Mendes V; Braun J; Thum P; von Bestenbostel R; Kurz C; Landry G; Reiner M; Niyazi M; Belka C; Corradini S
    Radiat Oncol; 2022 Mar; 17(1):53. PubMed ID: 35279185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.